Net Income (Annual) Chart

View Net Income (Annual) for LXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 -50.34M
December 31, 2024 -200.40M
December 31, 2023 -177.12M
December 31, 2022 -101.94M
December 31, 2021 -87.76M
December 31, 2020 -58.57M
December 31, 2019 130.13M
December 31, 2018 -120.55M
December 31, 2017 -122.99M
December 31, 2016 -141.43M
December 31, 2015 -4.682M
December 31, 2014 -100.29M
December 31, 2013 -104.13M
December 31, 2012 -110.21M
December 31, 2011 -116.22M
Date Value
December 31, 2010 -101.78M
December 31, 2009 -93.32M
December 31, 2008 -96.88M
December 31, 2007 -71.23M
December 31, 2006 -54.31M
December 31, 2005 -36.32M
December 31, 2004 -47.17M
December 31, 2003 -61.12M
December 31, 2002 -59.67M
December 31, 2001 -35.17M
December 31, 2000 -25.99M
December 31, 1999 -12.48M
December 31, 1998 -7.481M
December 31, 1997 -5.402M
December 31, 1996 -2.879M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Viatris, Inc. -3.515B
Pfizer Inc. 7.787B
ANI Pharmaceuticals, Inc. 71.37M
Corcept Therapeutics, Inc. 98.17M
Veru, Inc. -15.68M